JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McInnis, J.
Right arrow Articles by Johnson, K. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McInnis, J.
Right arrow Articles by Johnson, K. M.

Vol. 301, Issue 2, 478-487, May 2002

The Role of Superoxide and Nuclear Factor-kappa B Signaling in N-Methyl-D-aspartate-Induced Necrosis and Apoptosis

Justin McInnis, Cheng Wang , Noelle Anastasio, Mikael Hultman, YanPing Ye, Daniela Salvemini and Kenneth M. Johnson

Departments of Pharmacology and Toxicology (J.M., C.W., N.A., M.H., Y.Y., K.M.J.) and Psychiatry and Behavioral Science (C.W., K.M.J.), University of Texas Medical Branch, Galveston, Texas; and MetaPhore Pharmaceuticals (D.S.), St. Louis, Missouri

N-Methyl-D-aspartate (NMDA) receptor-mediated cell death is complex, probably involving elements of necrosis and apoptosis. The mechanisms underlying this phenomenon are incompletely understood but have been suggested to involve reactive oxygen species such as nitric oxide and superoxide anion (O&cjs1138;2) and nuclear factor-kappa B (NF-kappa B) signaling. In this study, we used a selective nonpeptidyl superoxide dismutase mimetic (M40403) and SN50, a peptide inhibitor of NF-kappa B translocation, to investigate the role of O&cjs1138;2 and the potential downstream signaling molecules in cell death induced by activation of the NMDA receptor. Application of NMDA to a mixed neuronal/glial forebrain culture resulted in an early increase in the release of cytoplasmic lactate dehydrogenase (LDH), which peaked at 4 h. This was followed by a reduction in mitochondrial metabolism of the dye MTT [3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyltetrazolium bromide] that continued to decrease throughout the 20-h exposure. A substantial increase in DNA fragmentation as measured by an enzyme-linked immunosorbent assay (ELISA) specific for DNA-associated histone proteins (nucleosomes) was observed at 7 and 20 h. M40403 and SN50 blocked NMDA-induced changes in LDH release at 2, 4, and 20 h, MTT metabolism at 4 and 20 h, and DNA fragmentation at 20 h as measured by the ELISA and by an increase in terminal dUTP-nick end labeling. M40403 also prevented NMDA-induced nuclear transport of NF-kappa B and increased expression of Bax relative to Bcl-XL. SN50 was also able to block NMDA-induced cell death as well as the increased Bax/Bcl-XL ratio. Time course studies and experiments with SN50 and M40403 suggest that O&cjs1138;2 production and NF-kappa B translocation may be involved in necrosis and apoptosis, but the latter also requires an increased expression of Bax. The ability of M40403 to prevent NMDA-induced cell death relatively early in this cascade suggests its potential therapeutic utility in central nervous systems diseases such as stroke that are associated with increased NMDA receptor-mediated production of O&cjs1138;2.

0022-3565/02/3012-0478$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2002 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 J. Pharmacol. Exp. Ther.Home page
S. Cuzzocrea, R. Di Paola, T. Genovese, E. Mazzon, E. Esposito, C. Crisafulli, P. Bramanti, and D. Salvemini
Anti-Inflammatory and Anti-Apoptotic Effects of Fumonisin B1, an Inhibitor of Ceramide Synthase, in a Rodent Model of Splanchnic Ischemia and Reperfusion Injury
J. Pharmacol. Exp. Ther., October 1, 2008; 327(1): 45 - 57.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
M. M. Ndengele, S. Cuzzocrea, E. Esposito, E. Mazzon, R. Di Paola, G. M. Matuschak, and D. Salvemini
Cyclooxygenases 1 and 2 contribute to peroxynitrite-mediated inflammatory pain hypersensitivity
FASEB J, September 1, 2008; 22(9): 3154 - 3164.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
Y. Kitaoka, Y. Kitaoka, J. M. K. Kwong, F. N. Ross-Cisneros, J. Wang, R. K. Tsai, A. A. Sadun, and T. T. Lam
TNF-{alpha}-Induced Optic Nerve Degeneration and Nuclear Factor-{kappa}B p65.
Invest. Ophthalmol. Vis. Sci., April 1, 2006; 47(4): 1448 - 1457.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
R. Garg, A. Chaudhuri, F. Munschauer, and P. Dandona
Hyperglycemia, Insulin, and Acute Ischemic Stroke: A Mechanistic Justification for a Trial of Insulin Infusion Therapy
Stroke, January 1, 2006; 37(1): 267 - 273.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Fujioka, C. Schmidt, G. M. Sclabas, Z. Li, H. Pelicano, B. Peng, A. Yao, J. Niu, W. Zhang, D. B. Evans, et al.
Stabilization of p53 Is a Novel Mechanism for Proapoptotic Function of NF-{kappa}B
J. Biol. Chem., June 25, 2004; 279(26): 27549 - 27559.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. Li, M. D. Southall, Q. Yi, Y. Pei, D. Lewis, M. Al-Hassani, D. Spandau, and J. B. Travers
The Epidermal Platelet-activating Factor Receptor Augments Chemotherapy-induced Apoptosis in Human Carcinoma Cell Lines
J. Biol. Chem., May 2, 2003; 278(19): 16614 - 16621.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
C. Wang, J. McInnis, J. B. West, J. Bao, N. Anastasio, J. A. Guidry, Y. Ye, D. Salvemini, and K. M. Johnson
Blockade of Phencyclidine-Induced Cortical Apoptosis and Deficits in Prepulse Inhibition by M40403, a Superoxide Dismutase Mimetic
J. Pharmacol. Exp. Ther., January 1, 2003; 304(1): 266 - 271.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2002 by the American Society for Pharmacology and Experimental Therapeutics.